chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day after receiving vaccines, right arm became red, swollen, itchy with a "bubbled up" appearance and or on white line around it. Went to ER, diagnosed with cellulitis, given Rx for KEFLEX. Seen for C/U in clinic with resolution by 7 days after vaccination.
At the time and date stated,  My whole body turned bright red in color, skin swelled and got hives all over, except for my face did not well or get hives, but my lips did start to swell some.  I did NOT have trouble breathing.  I went to the Emergency room.  The medications prescribed: Benedryl, Famotidine (pepcid) .  I did take the medication for five days as prescribed, symptoms did subside.  The ER doctor did recommend Not to receive the second dose of the Covid-19 vaccine due to possible more adverse affects or problems.
Local reaction of redness itching and swelling. Mom took to ER and received steroid shot.  Mom insisted a VAERS be submitted.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Patient medical history and current condition was not reported. On 08-APR-2015 the patient was vaccinated with RECOMBIVAX HB injection of strength 5/0.5 microgram/ml (lot t# K014548 and expiry date 27-AUG-2016) and PEDIARIX. No adverse symptoms reported. Product quality complaint was not reported. The outcome of the events was unknown. This is one of the two reports linked via sibling link (1504USA004476). Additional information has been requested.
1/9/2017 Rec'd 2nd meningococcal vaccine approximately 4:30 pm. Hot on Tuesday then high fever to 102.8 measured, nausea, HA, fatigue, depression, insomnia, chills W/sweats, neck lymph nodes inflamed and swollen.
Bilateral arm numbness starting approximately 36 hours post administration of the vaccine. Symptoms are only in the middle of the night. No numbness when upright and moving around.
I began to have a scab form where I was given the vaccine. The same scab that formed where I was given the vaccine moderna began to grow all over my body but in tiny hidden pieces.
Received H1N1 vaccine on 12/3/09. Went to ER on 12/9/09 with complaint of fever, vomiting and diarrhea.
Day after injection & since-severe headaches, nausea/vomiting, chest pressure, shortness of breath
Of note, STAT call for patient by MA upon immis as patient fainted, hit head on soft examination table and fell to the floor. Witnessed fall by MA, who reported on patient status. Upon quick evaluation, patient was quickly placed in trendelenburg position with pillow under head, vitals were checked, and an EKG was done, which showed low-normal heart rate but was otherwise reassuring. PAtient recovered well without sequelae. This is the first time this has happened to patient. Likely symptoms can be described as a vaso-vagal reaction and unlikely to be allergy to vaccination. In the future, it should be noted that patient should be in laying down position when administering vaccinations to avoid this potential complication in the future. The rest of physical exam was unremarkable.
Patient received Pfizer monovalent vaccine as a booster on 9/1/222. No symptoms.
pt recvd vax; exp fever, swelling & purple shiny discoloration of lt leg,about 10-11 hrs p/ vax;
Night of the vaccination had a fever of 102., body aches, chills and fatigue one night tired for a couple of days then three weeks later three weeks after vaccination had a fever body aches, chills, fatigue lasted 9 days, 3rd short ness of breath, 5th day  head aches,6th  blistered and body swelling, face swelling lips, neck and antiphallic  type. A week into the symptoms Tele visit  was told to take Benadryl next day, Emergency room  a week into the symptoms, after taking Benadryl and was not seeing relief. Right wrist blister and both arms and legs was swollen feet and ankle was swelling and over the weekend the swelling. 5lbs of water swelling.  Cold sweats through the symptoms.
On April 24, 2021, when I woke at about noon, I immediately experience very loud, disturbing tinnitus, with no apparent reason for it, such as having gone to a loud musical event, etc. I was immediately extremely uncomfortable with a borderline panic attack. From that point on, I have had tinnitus, chronic insomnia, and early I had very bad anxiety. I have NEVER had such a response in my entire life.
Day of injection: Fever of 101.6, extreme tenderness, fussiness, mood/behavioral changes, lethargy, crying, sleeplessness, restlessness, nausea. Day after injection: Same as above, with added large area of redness & skin is warm to the touch - both at injection site.
Achy joints  day two 4/7/21. Achy joints day three 4/8/21.  Fever of 101.6 on  day two 4/7/21. Fever 99.6 on day three 4/8/21.  Day 4 is normal.  Arm soreness starting on 2nd day, diminishing on day 4.  Large rash/redness around injection site starting on day 2 - still active on day 4 UNRESOLVED Itching now accompanying rash on day 4 UNRESOLVED
On May 20, 1999 the patient experienced chickenpox. The pt was afebrile and tired. No further information is available.
Had the vaccine --had shingles/ Suspected vaccination failure; Shingles; This case was reported by a consumer via  media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient received the Shingles vaccine and had shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Narrative:  COVID infection following COVID vaccine series 04/07, Moderna, dose #1 05/06, Moderna, dose #2 08/23 pt cc: cough, exposure: unknown 08/24 COVID swab, result: detected 08/24 SARS-COV-2 Variant Sequencing result: pending 10/01 COVID swab, result: not detected
Pain in chest, wheezing, uncontrollable coughing which lead to my throat feeling like it?s closing, all while sweating and feeling itchy all over body. Arm hurt super bad too. Doctors gave me epipen, Benadryl & steroids in the ER.  Doing better a day later.
HCP reports that improperly stored vaccines were administered. Names of vaccines involved (including lot/exp) PROQUAD (lot: W028561 exp:03/06/2024); No Additional AEs.; This spontaneous report has been received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported.  On an unknown date, the patient was vaccinated with an improper stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD), 1 time dose, (lot # W028561, has been verified to be a valid lot number for measles, mumps, rubella and varicella [oka-merck] virus vaccine live [PROQUAD], expiration date reported and upon internal validation established as 06-MAR-2024) for prophylaxis (exact dose, anatomical location, and route of administration were not reported). The vaccine was stored at a temperature of 7.7 Fahrenheit (F) for 8 hours and 54 minutes. It has previously suffered a temperature excursion at a temperature of 7.7F for 2 hours 18 minutes (Product storage error).  No adverse events were reported.
This infant had a fever of 104.9 several hours after his Prevnar administration. No localizing symptoms of infection found. Admitted to the hospital for R/0 sepsis. Lethargic. In the Blood cultures, urine cultures, CSF fluid not suggestive of infection. IV Ceftriaxone given.
Information has been received from a physician concerning a 16 year old female with obsessive-complusive disorder, panic attacks, anaemia, scoliosis with fusion (2005), and allergies to cat dander, pollen and grass who on 18-AUG-2007 was vaccinated with her first dose of 0.5 ml GARDASIL (Lot #653735/0688F) intramuscularly in the left arm. Concomitant therapy included NOVO-PAROXETINE and iron tablets (unspecified). These symptoms were reported to the physician during an appointment on 21-FEB-2008. The patient reported to the physician that after her first dose on 18-AUG-2007 she developed wheezing, a hoarse voice, and chest pain in the car after her vaccination. The patient said the chest pain traveled from her arm to her chest, and stopped near her neck. She also reported to the physician being anxious and feeling lightheaded. All symptoms resolved within two minutes. The patient had come to the physician's office on 21-FEB-2008 for a second dose GARDASIL. Due to the symptoms on the first dose, the patient was not given a second dose. Also, the patient had reported that she had a yeast allergy. She stated that she experienced swelling after eating a pizza. On 21-MAR-2008 the patient reported that she was joking about her yeast allergy. She is requesting the second dose of GARDASIL. There was no further information available. Additional information has been requested.
No additional information provided. No AE; VARIVAX was administered to a patient on 7/11. Caller then stated MMRII vaccine was administered on 7/18 instead of 4-week period between administrations; This spontaneous report has been received from a nurse, concerning a patient of unknown age and gender.  The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported.  On 11-JUL-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, and on 18-JUL-2023, instead of 4-week period between administrations, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, both vaccines administered as prophylaxis (exact doses, lot numbers, expiration dates, routes of administration, and anatomical locations were not provided) (Inappropriate schedule of product administration). The reporter confirmed that patient has not had any symptoms. No additional adverse events (AEs) nor information were provided.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. On 11-APR-2016, the patient was vaccinated intramuscularly with an expired dose of PNEUMOVAX 23, 0.5 ml, once (lot # K009874, expiration date: 19-MAR-2016). No adverse effects were reported. Additional information has been requested.
pt recv vax & w/in 24hr post vax pt exp a rash onto he lt forearm consisting of raised, red, small, itchy spots which spread to ankles;no tx given;sx resolved;
Post vax, the patient experienced a varicella like rash on his lower body. Medical attention was sought from a health care provider. The health care provider was not certain if the "break out was diaper rash or a reaction to the injection". Additional information has been requested.
patient was given a 3rd dose prior to 28 days after his 2nd dose/patient was given a 3rd dose and was not immunocompromised; This spontaneous case was reported by a pharmacist and describes the occurrence of OFF LABEL USE (patient was given a 3rd dose prior to 28 days after his 2nd dose/patient was given a 3rd dose and was not immunocompromised) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 051E21A and 052E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced OFF LABEL USE (patient was given a 3rd dose prior to 28 days after his 2nd dose/patient was given a 3rd dose and was not immunocompromised). On 18-Oct-2021, OFF LABEL USE (patient was given a 3rd dose prior to 28 days after his 2nd dose/patient was given a 3rd dose and was not immunocompromised) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The pharmacist reported that the patient had presented like it was his second dose but then after administering the dose, it was realized that it was a third dose. The patient was not immunocompromised.  Concomitant product use was not provided by the reporter. Treatment information was not provided by the reporter.
Mother called day after vaccines were given. She stated that the child had a 105 temp last night and that the child was favoring his left leg. Mom said that she gave Ibuprofen and that the fever was down today. I suggested that she take the child to his doctor and mom says he doesn't have one until he gets his shots.
Around 2 AM I woke up to my heart pounding. I went to the bathroom and felt faint upon standing. I checked my pulse it was approximately 150 BPM. I went back to bed because I felt extremely weak. I awoke with a huge lump at my injection site that was enflamed, itchy, and red. The roof of my mouth was itching severely. I took Benadryl. I called my doctors office the next day, they said I should be seen. I went in the following day, and the doctor told me that she'd "seen worse" and that it was "probably fine" as long as I am responding to Benadryl, and that COVID would be a lot worse. I went home and the lump has grown larger without subsiding. Still inflamed and itchy, but my doctor said that it is "totally normal".
has been on and off sleeping all day; she might have had a temperature, was very warm, and not reacting to him; had a rising in body, her entire body was in pain, she would have screamed if she could; she thought she was going to die; sounded to her son that it was very similar to what he had experienced with the flu or flu shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (had a rising in body, her entire body was in pain, she would have screamed if she could), FEELING ABNORMAL (she thought she was going to die), INFLUENZA (sounded to her son that it was very similar to what he had experienced with the flu or flu shot), POOR QUALITY SLEEP (has been on and off sleeping all day) and PYREXIA (she might have had a temperature, was very warm, and not reacting to him) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disorder (heart condition).   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PAIN (had a rising in body, her entire body was in pain, she would have screamed if she could), FEELING ABNORMAL (she thought she was going to die), INFLUENZA (sounded to her son that it was very similar to what he had experienced with the flu or flu shot) and PYREXIA (she might have had a temperature, was very warm, and not reacting to him). On 07-Mar-2021, the patient experienced POOR QUALITY SLEEP (has been on and off sleeping all day). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, PAIN (had a rising in body, her entire body was in pain, she would have screamed if she could), FEELING ABNORMAL (she thought she was going to die), INFLUENZA (sounded to her son that it was very similar to what he had experienced with the flu or flu shot), POOR QUALITY SLEEP (has been on and off sleeping all day) and PYREXIA (she might have had a temperature, was very warm, and not reacting to him) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had a walker to get around. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable. No relevant concomitant medications reported.
pt had fever of 104.4 and was admitted to Hospital for fevers and altered mental status. Patient is confused and has decrease extremity muscle strenght. Patient has aspriated resulting in intubation and placement in ICU. Pt current extubated. pt currently largely unresponsive to commands and is not AA0x3.
Patient reported allergic reaction after leaving pharmacy.  Patient reports going to Emergency department after experiencing rash and throat swelling.  Patient notified pharmacy by phone the next day.
Pt recieved shot and waited 15 mins inside clinic.  While walking to car, pt began to feel lightheaded and weak.  Also complained of chest pain.  Pt flagged down passerby but was too weak to walk back  into clinic.  Staff brought pt back into clinic via wheelchair. Vital signs stable.  Pt reported tingling in legs and numb face. EMS transported pt to hospital.
ERYTHEMA AND ECCHYMOSIS IN BOTH LEGS. SHE WAS SEEN BY A HEMATOLOGIST WHO HER OPINION INDICATES THAT SHE HAD A PURPURA POST COVID VACCINE.
Starting -4/12/2021 - initial symptoms cycled through over the first four weeks.  Fever, chills, aches, pains, shooting pain in ears (first 9 days); uncontrollable shaking, erratic heart beat  (April 17, 18); severe  head and neck ache (lasted 2 days), resting pulse 100, head cold, diarrhea, cough, fatigue, weakness, chest tightness, pneumonia (X-ray on 04/30/2021), premature heart beat (EKG on 05/17/2021).     As of 05/21/2021, still have heart beat irregularities, weakness, and fatigue.
Pt was lightheaded after receiving the vaccine. After she got something to drink she fainted and her significant other caught her. She began to vomit and was gently lowered to the ground. She was down there, conscious, for several minutes but eventually felt well enough to stand and left the store.
stroke; neurological issues; herpes zoster; Information has been received from a lawyer regarding a case in litigation and referring to a female patient (pt) of unknown age. Information about the pt's concurrent conditions, medical history and concomitant medications was not reported. On an unknown date, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, route of administration, anatomical location, lot # and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date, reported as after receiving zoster vaccine live (ZOSTAVAX), the pt suffered herpes zoster, neurological issues and a stroke. As a result of these symptoms, the pt was seen and treated by medical providers and at the time of report was still under their care. As a direct and proximate result of the defective zoster vaccine live (ZOSTAVAX) vaccine, the pt's symptoms had resulted in physical limitations not present prior to using the suspect product. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of pt's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was not recovered/not resolved. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).   Upon internal review, the event of stroke was determined to be medically significant. The events of herpes zoster, neurological issues and stroke were considered to be disabling.
Left shoulder pain, decreased range of motion, starting the day following vaccination.  Patient presented for primary care evaluation 1/9/23 with 6 weeks of symptoms.  Concern for bursitis, treated with prescription steroids, NSAIDs, and physical therapy referral.
It was reported that a 48 year old female patient received a TD Adult vaccination on 21 Feb 2001. Reportedly that same day the patient developed a local reaction of redness and swelling.
Information has been received from a physician referring to an unspecified number of patients of unknown age and gender. The patients' concurrent condition, medical history and concomitant therapy were not reported. On an unknown date, the patients were vaccinated with improperly stored vaccine ROTATEQ (dose, strength, frequency unknown) that underwent temperature excursion every day since May 2017. She also reported that the vaccines may also have had temperature excursions prior to May 2017. For ROTATEQ vaccine, lot numbers are:  N003401 expiration 13-OCT-2018, M031553 expiration 19-MAR-2018, L046320 expiration 29-SEP-2017. The vaccine was stored at 32 to 35 degrees Fahrenheit for 25 hours and 47 to 77 degrees Fahrenheit for 55 hours. For the lot number N003401, the administration dates are: 06-JUN-2017, 29-JUN-2017. Excursion temperatures and time: 8.11 to 11.7 degrees from 09-MAY-2017 to 16-MAY-2017 for 63 hours, 8.11 to 9.6 degrees from 25-MAY-2017 to 06-JUN-2017 for 46 hours, 8.6 to 8.7 degrees from 06-JUN-2017 to 29-JUN-2017 for 60 hours. For the lot number L046320, the administration dates are: 16-MAY-2017, 18-MAY-2017, 13-JUN-2017, 19-JUN-2017, 21-JUN-2017, 26-JUN-2017, 10-JUL-2017, 11-JUL-2017, 12-JUL-2017. The excursion temperatures and time: 8.9-11.7 degrees from 09-MAY-2017 to 16-MAY-2017 for 63 hours, 8.8 to 8.9 degrees from 25-MAY-2017 to 13-JUN-2017 for 73 hours, 8.7 degrees on 19-JUN-2017 for 5 hours and 47 minutes, 8.7 to 8.8 degrees from 15-JUN-2017 to 21-JUN-2017 for 30 hours and 30 minutes, 0.0 to 1.7 degrees from 30- JUN- 2017 to 10- JUL-2017 52 hours and 59 minutes, 0.2 degrees on 11-JUL-2017 for 9 hours and 45 minutes, -0.2 degrees on 12-JUL-2017 for 6 hours and 41 minutes. The phone call was a result of the data logger.  No adverse effects were reported. This is one of the several reports from the same reporter. This report has been linked to reports 1707USA002962, 1708USA004862 and 1708USA004863.; Sender's Comments: US-009507513-1707USA002962: US-009507513-1708USA004861: US-009507513-1708USA004863:
severe pain in knee; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (severe pain in knee) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced ARTHRALGIA (severe pain in knee). At the time of the report, ARTHRALGIA (severe pain in knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.   This case was linked to MOD-2021-044607 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: TCR document was attached. Patient still has knee pain.